Honigman completed the acquisition of Theratechnologies, Inc., a specialty biopharmaceutical business devoted to the commercialization of novel treatments, on behalf of CB Biotechnology, LLC, a subsidiary of Future Pak, LLC, a privately held contract manufacturer, packager, and distributor of pharmaceutical and nutraceutical products.